BrightEdge - American Cancer Society’s Post

Headed to #MedTech2025 in San Diego this week! Our Managing Director, Alice Lin Pomponio, will be joining the AdvaMed Accel Leadership Seminar: Finding the Path Forward – Alternative Sources of Financing for Medtech Innovation alongside Stephen Thau, Jarret Fass, Kylle Jordan, and Joe Heanue. The panel will highlight how alternative financing models from venture capital to mission-driven impact investing can accelerate medtech innovation and bring life-changing technologies to patients faster. That’s exactly what BrightEdge, the American Cancer Society’s innovation and impact investment arm, strive to do every day. Looking forward to the conversation and to connecting with others advancing progress in health innovation. #MedTech2025 #ImpactInvesting #HealthTechInnovation